The use of mass spectrometry to improve the diagnosis and the management of the HPA axis.

about

Effectiveness of Metyrapone in Treating Cushing's Syndrome: A Retrospective Multicenter Study in 195 Patients Variability in laboratory parameters used for management of Cushing's syndrome.Discordance between mass spectrometry and immunometric IGF-1 assay in pituitary disease: a prospective study.

P2860

Q33569920-83D48571-3A25-46B2-B047-E3AF81D6EC98 Q36327131-03A9DBA2-26C4-4EBE-9D4A-D100C9449F54 Q50017693-04B52126-1AD1-4D82-ABBD-0A1D65084495

P2860

The use of mass spectrometry to improve the diagnosis and the management of the HPA axis.

Item

http://www.wikidata.org/entity/Q38089640

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

The use of mass spectrometry to improve the diagnosis and the management of the HPA axis.

@en

type

Item

label

The use of mass spectrometry to improve the diagnosis and the management of the HPA axis.

@en

prefLabel

The use of mass spectrometry to improve the diagnosis and the management of the HPA axis.

@en

P1476

The use of mass spectrometry to improve the diagnosis and the management of the HPA axis.

@en

P2093

Brian G Keevil

http://www.w3.org/2001/XMLSchema#string

P2860

Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement.

Total testosterone assays in women with polycystic ovary syndrome: precision and correlation with hirsutism.

Validation of bioanalytical LC-MS/MS assays: evaluation of matrix effects.

Pitfalls associated with the use of liquid chromatography-tandem mass spectrometry in the clinical laboratory.

The cortisol response to awakening in relation to different challenge tests and a 12-hour cortisol rhythm.

Ion suppression in mass spectrometry.

Advantage of salivary cortisol measurements in the diagnosis of glucocorticoid related disorders.

The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.

Utility of salivary cortisol measurements in Cushing's syndrome and adrenal insufficiency.

Urine steroid metabolomics as a biomarker tool for detecting malignancy in adrenal tumors

P2888

s11154-013-9240-1

P304

143-157

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11154-013-9240-1

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Peter J. Trainer

Phillip J. Monaghan

P577

2013-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1001209770

http://www.w3.org/2001/XMLSchema#string

P698

23494459

http://www.w3.org/2001/XMLSchema#string

The use of mass spectrometry to improve the diagnosis and the management of the HPA axis.

about

P2860

P2860

The use of mass spectrometry to improve the diagnosis and the management of the HPA axis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698